Radiopharmaceuticals Global Market Report 2022 – By Type (Diagnostic, Therapeutic), By Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinnology, Neurology, Nephrology), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026

What is the definition of the radiopharmaceuticals market?

The radiopharmaceuticals market consists of sales of radiopharmaceuticals and related services by entities (organizations, sole traders, and partnerships) that produce radiopharmaceuticals used in treating cancer, cardiovascular, and other diseases. Radiopharmaceuticals are radioactive compounds administered to the patients, monitored via specific imaging devices, and used for diagnostic and therapeutic purposes.

How will the radiopharmaceuticals market drivers and restraints affect radiopharmaceuticals market dynamics? What forces will shape the radiopharmaceuticals industry going forward?

The radiopharmaceuticals market growth is aided by increasing prevalence of cancer and cardiovascular diseases. However, some radiopharmaceuticals market restraints include high cost of radiopharmaceuticals

What is the forecast market size of the radiopharmaceuticals market?

The radiopharmaceuticals market forecast is expected to reach $6.75 billion in 2025 at a compound annual growth rate of 7%.

How is the radiopharmaceuticals market segmented?

The global radiopharmaceuticals market is segmented -
1) By Type: Diagnostic, Therapeutic, Others
2) By Application: Oncology, Cardiology, Gastroenterology, Neuroendocrinnology, Neurology, Nephrology, Others
3) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Others

Which region has largest share, and what is the market size and growth by geography according to the radiopharmaceuticals global market report?

For more detail on this, request a sample here.

Who are the key players of the global radiopharmaceuticals market?

Top competitors in the radiopharmaceuticals market are Siemens Healthcare Private Limited, Bayer, GE Healthcare, Novartis AG, Cardinal Health, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Nordion Inc. (A Subsidiary of Sterigenics International),

What are the key trends in the global radiopharmaceuticals market?

Major trends influencing the radiopharmaceuticals market include adopting various strategic initiatives such as opening a new manufacturing facility and plant capacity expansion

What are the major opportunities in the radiopharmaceuticals market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global radiopharmaceuticals market, request a sample here

How does the radiopharmaceuticals market relate to the overall economy and other similar markets?

For this and further detailed insights on the market, request a sample here.

Call Us

+1 3156230293


+44 2071930708


+91 8897263534

(Asia & Others)